Literature DB >> 15378056

Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness.

Ted Cohen1, Megan Murray.   

Abstract

Mathematical models have recently been used to predict the future burden of multidrug-resistant tuberculosis (MDRTB). These models suggest the threat of multidrug resistance to TB control will depend on the relative 'fitness' of MDR strains and imply that if the average fitness of MDR strains is considerably less than that of drug-sensitive strains, the emergence of resistance will not jeopardize the success of tuberculosis control efforts. Multidrug resistance in M. tuberculosis is conferred by the sequential acquisition of a number of different single-locus mutations that have been shown to have heterogeneous phenotypic effects. Here we model the impact of initial fitness estimates on the emergence of MDRTB assuming that the relative fitness of MDR strains is heterogeneous. We find that even when the average relative fitness of MDR strains is low and a well-functioning control program is in place, a small subpopulation of a relatively fit MDR strain may eventually outcompete both the drug-sensitive strains and the less fit MDR strains. These results imply that current epidemiological measures and short-term trends in the burden of MDRTB do not provide evidence that MDRTB strains can be contained in the absence of specific efforts to limit transmission from those with MDR disease.

Entities:  

Mesh:

Year:  2004        PMID: 15378056      PMCID: PMC2652755          DOI: 10.1038/nm1110

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  26 in total

1.  Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

Authors:  A van Rie; R Warren; M Richardson; T C Victor; R P Gie; D A Enarson; N Beyers; P D van Helden
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

Review 2.  The biological cost of antibiotic resistance.

Authors:  D I Andersson; B R Levin
Journal:  Curr Opin Microbiol       Date:  1999-10       Impact factor: 7.934

3.  To treat or not to treat: the case of tuberculosis.

Authors:  C Castillo-Chavez; Z Feng
Journal:  J Math Biol       Date:  1997-06       Impact factor: 2.259

4.  Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy.

Authors:  C Dye; G P Garnett; K Sleeman; B G Williams
Journal:  Lancet       Date:  1998-12-12       Impact factor: 79.321

5.  Modeling the impact of global tuberculosis control strategies.

Authors:  C J Murray; J A Salomon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

Review 6.  Understanding, predicting and controlling the emergence of drug-resistant tuberculosis: a theoretical framework.

Authors:  S M Blower; J L Gerberding
Journal:  J Mol Med (Berl)       Date:  1998-08       Impact factor: 4.599

Review 7.  Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus".

Authors:  P Farmer; J Y Kim
Journal:  BMJ       Date:  1998-09-05

8.  The population dynamics of antimicrobial chemotherapy.

Authors:  M Lipsitch; B R Levin
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

9.  The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection.

Authors:  E Vynnycky; P E Fine
Journal:  Epidemiol Infect       Date:  1997-10       Impact factor: 2.451

10.  Adaptation to the fitness costs of antibiotic resistance in Escherichia coli.

Authors:  S J Schrag; V Perrot; B R Levin
Journal:  Proc Biol Sci       Date:  1997-09-22       Impact factor: 5.349

View more
  98 in total

1.  Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations.

Authors:  Ted Cohen; Marc Lipsitch; Rochelle P Walensky; Megan Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

2.  The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.

Authors:  Gwenan M Knight; Caroline Colijn; Sourya Shrestha; Mariam Fofana; Frank Cobelens; Richard G White; David W Dowdy; Ted Cohen
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

3.  One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America.

Authors: 
Journal:  AIDS       Date:  2017-01-28       Impact factor: 4.177

4.  Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.

Authors:  Daniel E Rozen; Lesley McGee; Bruce R Levin; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

5.  Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission.

Authors:  Ted Cohen; Caroline Colijn; Bryson Finklea; Megan Murray
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

Review 6.  The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study.

Authors:  L Temime; G Hejblum; M Setbon; A J Valleron
Journal:  Epidemiol Infect       Date:  2007-09-04       Impact factor: 2.451

Review 7.  Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis.

Authors:  Christopher Dye
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

Review 8.  The transmission and control of XDR TB in South Africa: an operations research and mathematical modelling approach.

Authors:  S Basu; A P Galvani
Journal:  Epidemiol Infect       Date:  2008-07-07       Impact factor: 2.451

Review 9.  The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis.

Authors:  Borna Müller; Sonia Borrell; Graham Rose; Sebastien Gagneux
Journal:  Trends Genet       Date:  2012-12-13       Impact factor: 11.639

10.  Antituberculosis activity of the molecular libraries screening center network library.

Authors:  Joseph A Maddry; Subramaniam Ananthan; Robert C Goldman; Judith V Hobrath; Cecil D Kwong; Clinton Maddox; Lynn Rasmussen; Robert C Reynolds; John A Secrist; Melinda I Sosa; E Lucile White; Wei Zhang
Journal:  Tuberculosis (Edinb)       Date:  2009-09-26       Impact factor: 3.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.